RJR will have to pay Altria only half of the originally determined ongoing royalties. Read More
Tags :Vuse
The firm insists its product are appropriate for the protection of public health.Read More
RJR presented insufficient evidence that potential benefit outweighs risks. Read More
Featured
Intellectual Property
Litigation
News This Week
Reynolds Vapor Denied New Trial in Vuse Case
Judge N. Carlton Tilley Jr. rejects Reynolds’ assertion that the original trial was unfair. Read More
The company believes the lawsuit was filed in retaliation for its complaint against IQOS. Read More
Reynold’s brand pulls ahead as Juul Labs wrestles with regulatory uncertainty. Read More
Featured
Intellectual Property
Litigation
News This Week
Reynolds Hit with $95 Million Verdict in Vapor Patent Dispute
A jury finds that Vuse Alto infringes three Altria patents.Read More
Confusion around the FDA’s marketing denial order contributed to Juul’s retreat. Read More
The recent FDA ruling opens the door to market dominance, says financial advice company. Read More
The case is part of multi-front patent dispute involving IQOS and RJR's Vuse.Read More
